RetractedTrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2019

TBCRC026: Phase II Trial Correlating Standardized Uptake Value With Pathologic Complete Response to Pertuzumab and Trastuzumab in Breast Cancer.

Roisin M Connolly et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.